Raoying Xie

1.2k total citations
21 papers, 685 citations indexed

About

Raoying Xie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Raoying Xie has authored 21 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Raoying Xie's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Raoying Xie is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Raoying Xie collaborates with scholars based in China, United States and Israel. Raoying Xie's co-authors include Xiaolin Lin, Yujuan Qin, Sheng Yang, Huafang Su, Dong Xiao, Hui Zhang, Jianwei Zhou, Huiyan Wang, Kang Xu and Lin Chen and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Transplantation.

In The Last Decade

Raoying Xie

20 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raoying Xie China 13 442 387 139 115 42 21 685
Hongxing Shen United States 13 400 0.9× 353 0.9× 119 0.9× 121 1.1× 36 0.9× 22 672
Enhua Wang China 16 651 1.5× 614 1.6× 154 1.1× 92 0.8× 29 0.7× 26 867
Yibing Fu China 13 372 0.8× 274 0.7× 76 0.5× 99 0.9× 29 0.7× 20 598
Shengchun Wang China 13 713 1.6× 466 1.2× 98 0.7× 68 0.6× 26 0.6× 36 965
Xiaoling Wu China 21 758 1.7× 543 1.4× 170 1.2× 79 0.7× 28 0.7× 54 996
Liang Hao China 15 494 1.1× 211 0.5× 207 1.5× 81 0.7× 35 0.8× 37 734
Xiaopeng Cui China 17 470 1.1× 244 0.6× 137 1.0× 77 0.7× 27 0.6× 35 676
Monika Zajkowska Poland 14 233 0.5× 189 0.5× 230 1.7× 140 1.2× 21 0.5× 46 550
Yanhui Yin China 16 426 1.0× 176 0.5× 207 1.5× 238 2.1× 48 1.1× 27 725

Countries citing papers authored by Raoying Xie

Since Specialization
Citations

This map shows the geographic impact of Raoying Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raoying Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raoying Xie more than expected).

Fields of papers citing papers by Raoying Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raoying Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raoying Xie. The network helps show where Raoying Xie may publish in the future.

Co-authorship network of co-authors of Raoying Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Raoying Xie. A scholar is included among the top collaborators of Raoying Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raoying Xie. Raoying Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xia, Kejie Li, Xuemei Zhang, et al.. (2025). The clinical value of FAPI PET/CT in delineating target volumes for nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 53(1). 105–115.
3.
Ren, Xiaolin, Huijuan He, Dahai Zhang, et al.. (2023). Curcumol β-cyclodextrin inclusion complex enhances radiosensitivity of esophageal cancer under hypoxic and normoxic condition. Japanese Journal of Radiology. 41(11). 1275–1289. 7 indexed citations
4.
Xu, Kang, Raoying Xie, Xiaolin Lin, et al.. (2020). Brown Adipose Tissue: A Potential Site for Islet Transplantation. Transplantation. 104(10). 2059–2064. 12 indexed citations
6.
Zhou, Yongqiang, et al.. (2020). miR-18a increases insulin sensitivity by inhibiting PTEN. Aging. 13(1). 1357–1368. 12 indexed citations
7.
Fei, Zhenghua, et al.. (2019). Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling. Toxicology and Applied Pharmacology. 371. 55–62. 50 indexed citations
8.
Li, Kejie, et al.. (2019). PD-L1 Induces Epithelial‐Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(7). 801–807. 30 indexed citations
10.
Chen, Wenhao, Hui Zhang, Wenyi Zhang, et al.. (2019). Development of a contouring guide for three different types of optic chiasm: A practical approach. Journal of Medical Imaging and Radiation Oncology. 63(5). 657–664. 3 indexed citations
11.
Xie, Raoying, et al.. (2018). Artesunate enhances radiosensitivity of esophageal cancer cells by inhibiting the repair of DNA damage. Journal of Pharmacological Sciences. 138(2). 131–137. 27 indexed citations
12.
Zhou, Jianwei, et al.. (2018). LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer progression by upregulating KLF14. Biochemical and Biophysical Research Communications. 503(3). 1848–1853. 79 indexed citations
13.
Xie, Raoying, Linhui Ruan, Lei Chen, et al.. (2017). T2 relaxation time for intervertebral disc degeneration in patients with upper back pain: initial results on the clinical use of 3.0 Tesla MRI. BMC Medical Imaging. 17(1). 9–9. 10 indexed citations
14.
Xie, Raoying, Xiaolin Lin, Tao Du, et al.. (2016). Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway. Medicine. 95(7). e2713–e2713. 55 indexed citations
15.
Rong, Xiaoxiang, Wei Fang, Xiaolin Lin, et al.. (2015). Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition. OncoImmunology. 5(3). e1086060–e1086060. 35 indexed citations
16.
Lin, Xiaolin, Jun-Shuang Jia, Yujuan Qin, et al.. (2015). Simple and rapid determination of homozygous transgenic mice viain vivofluorescence imaging. Oncotarget. 6(36). 39073–39087. 9 indexed citations
17.
Wei, Fang, Xiaoxiang Rong, Raoying Xie, et al.. (2015). Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition. Oncotarget. 6(33). 35023–35039. 40 indexed citations
18.
Wang, Shengchun, Xiaolin Lin, Jing Li, et al.. (2014). MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA. PLoS ONE. 9(7). e101330–e101330. 101 indexed citations
19.
Du, Tao, Jun-Shuang Jia, Xiaolin Lin, et al.. (2013). Generation of Rm21LG transgenic mice: a powerful tool to generate conditional overexpression of miR-21 that is involved in oncogenesis. Biotechnology Letters. 36(1). 9–20. 10 indexed citations
20.
Gao, Fei, Wentao Zhao, Shengchun Wang, et al.. (2013). miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochemical and Biophysical Research Communications. 431(3). 610–616. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026